Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 29, 2016 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines to Present at the World Vaccine Congress Washington

CAMBRIDGE, Mass., March 29, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) is scheduled to present at the World Vaccine Congress Washington on Wednesday, March 30th, 2016 at 12:10...
March 07, 2016 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines Presents New Data Supporting its Glioblastoma Immunotherapy Program at the Keystone Symposia Cancer Vaccines Conference

CAMBRIDGE, Mass., March 07, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) today will present new data supporting its glioblastoma multiforme (“Glioblastoma” or “GBM”) cancer...
March 03, 2016 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines to Present at the ROTH Conference

CAMBRIDGE, Mass., March 03, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) is scheduled to present at the 28th Annual ROTH Conference on Tuesday, March 15th, 2016 at 5:30 PM PT...
February 09, 2016 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines Announces Research Collaboration with GlaxoSmithKline to Enhance Vaccine Stability

CAMBRIDGE, Mass., Feb. 09, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) has entered into a research collaboration with GlaxoSmithKline Biologicals SA (“GSK”) to evaluate VBI’s...
February 04, 2016 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines Partners with the Canadian CMV Foundation to Raise Congenital Cytomegalovirus Awareness

CAMBRIDGE, Mass., Feb. 04, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) is proud to announce its continued sponsorship support of Le Classique, the Canadian CMV Foundation’s...
January 26, 2016 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines to Present at the BIO CEO & Investor Conference

CAMBRIDGE, Mass., Jan. 26, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) is scheduled to present at the BIO CEO & Investor Conference on Tuesday, February 9th, 2016 at 1:00 PM...
January 18, 2016 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines to Present at the Noble Financial Emerging Growth Investor Conference

CAMBRIDGE, Mass., Jan. 18, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) is scheduled to present at the Noble Financial Emerging Growth Investor Conference on Monday, January...
November 25, 2015 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines to Present at the LD Micro Conference

CAMBRIDGE, Mass., Nov. 25, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") is scheduled to present at the Eighth Annual LD Micro Conference on Thursday, December 3rd, 2015 at 1:30 PM ET...
November 20, 2015 08:40 ET | Source: VBI Vaccines, Inc.

VBI Vaccines Presents Update and New Data Supporting its Glioblastoma Immunotherapy Program at the ESMO Symposium on Immuno-Oncology

CAMBRIDGE, Mass., Nov. 20, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) ("VBI") today presented an update and new data supporting its glioblastoma multiforme ("Glioblastoma" or "GBM")...
November 06, 2015 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines to Present Update and New Data Supporting its RSV and CMV Vaccine Programs at the World Vaccine Congress Europe

CAMBRIDGE, Mass., Nov. 6, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) ("VBI") is scheduled to present at the 16th Annual World Vaccine Congress Europe on Tuesday, November 10th, 2015 at...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right